Expression of p150 in cervical neoplasia and its potential value in predicting survival

Cancer

Volumn 83, Issue 7, 1998, Pages 1376-1383

  Dellas, Athanassios ^a   Torhorst, Joachim ^a   Bachmann, Felix ^b   Bänziger, Rahel ^b   Schultheiss, Elisabeth ^a   Burger, Max M ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Cervical neoplasia; Immunohistochemistry; P150; Prognosis

Indexed keywords

PROTEIN; PROTEIN P 150; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WART VIRUS;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CYTOSKELETAL PROTEINS; DISEASE-FREE SURVIVAL; EUKARYOTIC INITIATION FACTOR-3; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0032189714     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1     Document Type: Article

References (13)

1. National Cancer Institute. Cancer rates and risks. Bethesda, MA: National Institutes of Health, U.S. Department of Health and Human Services, 1996.
2. Bachmann F, Bänziger R, Burger MM. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res 1997;57:988-94.
3. Burghardt E. Prognostic Factors. In: Burghardt E, editor. Surgical gynecologic oncology. Stuttgart: Thieme Medical Publishers, 1993;315-33.
4. Fuller AF Jr., Molpus KL. Prognostic factors in early invasive cervical carcinoma. In: Rubin SC, Hoskins WJ, editors. Cervical cancer and preinvasive neoplasia. Philadelphia: Lippincott-Raven Publishers, 1996;219-43.
5. Robert ME, Fu YS. Squamous cell carcinoma of the uterine cervix: a review with emphasis on prognostic factors and unusual variants. Semin Diagn Pathol 1990;7:173-89.
6. Dellas A, Schultheiss E, Almendral AC, Torhorst J, Gudat F. Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki-67 distribution in cervical intra-epithelial neoplasms, Int J Cancer 1996;69:165-9.
7. Dellas A, Schultheiss E, Oberholzer M, Torhorst J, Gudat F. Analysis of proliferative activity using Ki-67 on cervical precancerous lesions and the relationship to p53 expression. Anticancer Res 1996;16:3403-7.
8. Jakobsen A, Bichel P, Vaeth M. New prognostic factors in squamous cell carcinoma of cervix uteri. Am J Clin Oncol 1985;8:39-43.
9. Cole DJ, Brown DC, Crossley E, Alcock CJ, Gatter KC. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer 1992;65: 783-5.
10. Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 1992;69:1750-8.
11. Dellas A, Moch H, Schultheiss E, Feichter G, Almendral AC, Gudat F, et al. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecol Oncol 1997;67:27-33.
12. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
13. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57:1083-93.